相似文献
1
Do DNA ploidy and S-phase fraction in primary tumour predict the response to chemotherapy in metastatic breast cancer?
Br J Cancer. 1995 May;71(5):1029-32. doi: 10.1038/bjc.1995.198.
2
Predictive value of topoisomerase IIalpha and other prognostic factors for epirubicin chemotherapy in advanced breast cancer.
Br J Cancer. 1998 Jun;77(12):2267-73. doi: 10.1038/bjc.1998.377.
3
Lack of prognostic significance of DNA ploidy and S phase fraction in breast cancer.
Br J Cancer. 1992 Nov;66(5):925-9. doi: 10.1038/bjc.1992.387.
4
Docetaxel followed by fluorouracil/epirubicin/cyclophosphamide as neoadjuvant chemotherapy for patients with primary breast cancer.
Jpn J Clin Oncol. 2011 Jul;41(7):867-75. doi: 10.1093/jjco/hyr081.
5
Progression and survival in prostatic adenocarcinoma: a comparison of clinical stage, Gleason grade, S-phase fraction and DNA ploidy.
Br J Cancer. 1994 Aug;70(2):309-14. doi: 10.1038/bjc.1994.298.
6
Accelerated-intensified cyclophosphamide, epirubicin, and fluorouracil (CEF) compared with standard CEF in metastatic breast cancer patients: results of a multicenter, randomized phase III study of the Italian Gruppo Oncologico Nord-Ouest-Mammella Inter Gruppo Group.
J Clin Oncol. 2001 Apr 15;19(8):2213-21. doi: 10.1200/JCO.2001.19.8.2213.
7
High-dose epirubicin + cyclophosphamide (HD-EC) in metastatic breast cancer: a dose-finding study.
Onkologie. 1988 Dec;11(6):287-8. doi: 10.1159/000216559.
8
Markers of prognosis in breast cancer--the relationship between binding of the lectin HPA and histological grade, SPF, and ploidy.
Breast Cancer Res Treat. 1993;25(3):247-56. doi: 10.1007/BF00689839.
9
Prediction of pathologic complete response to sequential paclitaxel and 5-fluorouracil/epirubicin/cyclophosphamide therapy using a 70-gene classifier for breast cancers.
Cancer. 2011 Aug 15;117(16):3682-90. doi: 10.1002/cncr.25953. Epub 2011 Feb 8.
10
Association between c-myc amplification and pathological complete response to neoadjuvant chemotherapy in breast cancer.
Eur J Cancer. 2011 Aug;47(12):1779-88. doi: 10.1016/j.ejca.2011.06.017. Epub 2011 Jul 7.
引用本文的文献
1
DNA ploidy and S-phase fraction analysis in peritoneal carcinomatosis from ovarian cancer: correlation with clinical pathological factors and response to chemotherapy.
Onco Targets Ther. 2017 Sep 20;10:4657-4664. doi: 10.2147/OTT.S141117. eCollection 2017.
2
The combination of Ki67, histological grade and estrogen receptor status identifies a low-risk group among 1,854 chemo-naïve women with N0/N1 primary breast cancer.
Springerplus. 2013 Dec;2(1):111. doi: 10.1186/2193-1801-2-111. Epub 2013 Mar 14.
3
Identification of hypermethylated genes associated with cisplatin resistance in human cancers.
Cancer Res. 2010 Apr 1;70(7):2870-9. doi: 10.1158/0008-5472.CAN-09-3427. Epub 2010 Mar 9.
4
Reliability of cyclin A assessment on tissue microarrays in breast cancer compared to conventional histological slides.
Br J Cancer. 2006 Jun 5;94(11):1697-702. doi: 10.1038/sj.bjc.6603147.
5
A model of quiescent tumour microregions for evaluating multicellular resistance to chemotherapeutic drugs.
Br J Cancer. 2005 Aug 8;93(3):302-9. doi: 10.1038/sj.bjc.6602710.
6
A high proliferation rate measured by cyclin A predicts a favourable chemotherapy response in soft tissue sarcoma patients.
Br J Cancer. 1999 Nov;81(6):1017-21. doi: 10.1038/sj.bjc.6690801.
7
Increased doxorubicin uptake and toxicity in multicellular tumour spheroids treated with DC electrical fields.
Br J Cancer. 1999 Jun;80(8):1204-13. doi: 10.1038/sj.bjc.6690487.
8
Prognosis and prediction of response in breast cancer: the current role of the main biological markers.
Cell Prolif. 1998 Jun-Aug;31(3-4):113-26. doi: 10.1046/j.1365-2184.1998.t01-1-00114.x.
9
A multivariate analysis of tumour biological factors predicting response to cytotoxic treatment in advanced breast cancer.
Br J Cancer. 1998 Sep;78(6):812-5. doi: 10.1038/bjc.1998.584.
10
Predictive value of topoisomerase IIalpha and other prognostic factors for epirubicin chemotherapy in advanced breast cancer.
Br J Cancer. 1998 Jun;77(12):2267-73. doi: 10.1038/bjc.1998.377.
本文引用的文献
1
Influence of treatment schedule on toxicity and efficacy of cyclophosphamide, epirubicin, and fluorouracil in metastatic breast cancer: a randomized trial comparing weekly and every-4-week administration.
J Clin Oncol. 1993 Mar;11(3):467-73. doi: 10.1200/JCO.1993.11.3.467.
2
How to integrate steroid hormone receptor, flow cytometric, and other prognostic information in regard to primary breast cancer.
Cancer. 1993 Mar 15;71(6 Suppl):2157-62. doi: 10.1002/1097-0142(19930315)71:6+<2157::aid-cncr2820711606>3.0.co;2-o.
3
Cell cycle modifications of breast cancers during neoadjuvant chemotherapy: a flow cytometry study on fine needle aspirates.
Eur J Cancer. 1993;29A(13):1843-8. doi: 10.1016/0959-8049(93)90534-m.
4
Differential killing efficacy of twenty antitumor drugs on proliferating and nonproliferating human tumor cells.
Cancer Res. 1981 Jun;41(6):2328-33.
5
Method for analysis of cellular DNA content of paraffin-embedded pathological material using flow cytometry.
J Histochem Cytochem. 1983 Nov;31(11):1333-5. doi: 10.1177/31.11.6619538.
6
Association of DNA index and S-phase fraction with prognosis of nodes positive early breast cancer.
Cancer Res. 1987 Sep 1;47(17):4729-35.
7
Aneuploid DNA content and high S-phase fraction of tumour cells are related to poor prognosis in patients with primary breast cancer.
Eur J Cancer Clin Oncol. 1987 Mar;23(3):277-82. doi: 10.1016/0277-5379(87)90071-x.
8
Histological grade, elastosis, DNA ploidy and the response to chemotherapy of breast cancer.
Br J Cancer. 1987 Apr;55(4):455-7. doi: 10.1038/bjc.1987.89.
9
Improving the prognostic value of DNA flow cytometry in breast cancer by combining DNA index and S-phase fraction. A proposed classification of DNA histograms in breast cancer.
Cancer. 1988 Nov 15;62(10):2183-90. doi: 10.1002/1097-0142(19881115)62:10<2183::aid-cncr2820621019>3.0.co;2-b.
10
Correlation of pretreatment proliferative activity of breast cancer with the response to cytotoxic chemotherapy.
J Natl Cancer Inst. 1989 Sep 20;81(18):1383-7. doi: 10.1093/jnci/81.18.1383.
Zotero 插件